ASH VTE Guidelines: Treatment of Deep Vein Thrombosis and Pulmonary Embolism
The purpose of this guideline is to provide evidence-based recommendations about the treatment of DVT and PE in patients without cancer. The target audience includes patients, hematologists, general practitioners, internists, hospitalists, vascular interventionalists, intensivists, other clinicians, pharmacists, and decision-makers.
Access the full guidelines on the Blood Advances website:
This guideline is endorsed by:
Guideline Implementation Tools and Resources
VTE Guidelines: What You Should Know
This one-page snapshot provides a high-level summary of the treatment of deep vein thrombosis and pulmonary embolism, covering the initial management, primary treatment, and secondary prevention phases. A snapshot of the full VTE guidelines is also available for download.
ASH Clinical Practice Guidelines App
The ASH Clinical Practice Guidelines App provides easy access to every recommendation from all guidelines published by ASH, including rationale for each recommendation, benefits and harms associated with each recommended course of action, and links to the complete evidence-to-decision tables used to develop the recommendations. This app is also available via web interface.
Help your colleagues diagnose, manage, and treat VTE using teaching slides designed for easy dissemination.
- Teaching slides for optimal treatment of deep vein thrombosis and pulmonary embolism
Powerpoint | PDF
- Anticoagulation Therapy
- Heparin-Induced Thrombocytopenia (HIT)
- Prevention in Surgical Patients
- Prophylaxis for Medical Patients
- Use of Anticoagulation in COVID-19
- ASH VTE Guidelines for Latin America Adaptations